Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imiquimod Induces Complete Clearance of a PUVA-Resistant Plaque in Mycosis fungoides
Reinhard Dummer, Mirjana Urosevic, Werner Kempf, et al.
Dermatology (2003) Vol. 207, Iss. 1, pp. 116-118
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Immunopathogenesis and therapy of cutaneous T cell lymphoma
Ellen J. Kim, Stephen D. Hess, Stephen K. Richardson, et al.
Journal of Clinical Investigation (2005) Vol. 115, Iss. 4, pp. 798-812
Open Access | Times Cited: 400
TLR7 and TLR8 as targets in cancer therapy
Michael P. Schön, Michael P. Schön
Oncogene (2008) Vol. 27, Iss. 2, pp. 190-199
Closed Access | Times Cited: 281
Mycosis fungoides and Sézary syndrome
Samuel Hwang, John E. Janik, Elaine S. Jaffe, et al.
The Lancet (2008) Vol. 371, Iss. 9616, pp. 945-957
Closed Access | Times Cited: 267
In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
Linda Hammerich, Adam Binder, Joshua Brody
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1966-1981
Open Access | Times Cited: 159
Evolving Insights in the Pathogenesis and Therapy of Cutaneous T‐cell lymphoma (Mycosis Fungoides and Sezary Syndrome)
Henry K. Wong, Anjali Mishra, Timothy S. Hake, et al.
British Journal of Haematology (2011) Vol. 155, Iss. 2, pp. 150-166
Open Access | Times Cited: 144
Immunopathogenesis and therapy of cutaneous T cell lymphoma
E. J. Kim
Journal of Clinical Investigation (2005) Vol. 115, Iss. 4, pp. 798-812
Open Access | Times Cited: 148
In Situ Vaccination for the Treatment of Cancer
Linda Hammerich, Nina Bhardwaj, Holbrook E. Kohrt, et al.
Immunotherapy (2016) Vol. 8, Iss. 3, pp. 315-330
Closed Access | Times Cited: 84
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Kazuyasu Fujii
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 68
Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas
Reinhard Dummer, Jessica C. Hassel, Friederike Fellenberg, et al.
Blood (2004) Vol. 104, Iss. 6, pp. 1631-1638
Open Access | Times Cited: 107
Clinical investigations of Toll-like receptor agonists
Thomas Meyer, Eggert Stockfleth
Expert Opinion on Investigational Drugs (2008) Vol. 17, Iss. 7, pp. 1051-1065
Closed Access | Times Cited: 77
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 42
Topical Immunomodulation in Dermatology: Potential of Toll-like Receptor Agonists
Ulrich R. Hengge, Thomas Ruzicka
Dermatologic Surgery (2004) Vol. 30, Iss. 8, pp. 1101-1112
Closed Access | Times Cited: 71
Granulomatous slack skin disease: a review, in comparison with mycosis fungoides
Apurva Shah, Anil Safaya
Journal of the European Academy of Dermatology and Venereology (2012) Vol. 26, Iss. 12, pp. 1472-1478
Closed Access | Times Cited: 42
New treatment options for mycosis fungoides
Alexa R. Shipman, Julia Scarisbrick
Indian Journal of Dermatology (2016) Vol. 61, Iss. 1, pp. 119-119
Open Access | Times Cited: 33
Toll‐like receptor ligands as adjuvants in allergen‐specific immunotherapy
Pål Johansen, Gabriela Senti, Julia M. Martínez Gómez, et al.
Clinical & Experimental Allergy (2005) Vol. 35, Iss. 12, pp. 1591-1598
Closed Access | Times Cited: 58
Role of Imiquimod in Skin Cancer Treatment
Mirjana Urosevic, Reinhard Dummer
American Journal of Clinical Dermatology (2004) Vol. 5, Iss. 6, pp. 453-458
Closed Access | Times Cited: 48
Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (AldaraR)
Biagio Didona, Roberto Benucci, Paolo Amerio, et al.
British Journal of Dermatology (2004) Vol. 150, Iss. 6, pp. 1198-1201
Closed Access | Times Cited: 45
Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series
Daniel J. Lewis, Yevgeniya A. Byekova, Drew A. Emge, et al.
Journal of Dermatological Treatment (2017) Vol. 28, Iss. 6, pp. 567-569
Closed Access | Times Cited: 25
Use of topical immunomodulators in organ transplant recipients
Bradley T. Kovach, Thomas Stasko
Dermatologic Therapy (2005) Vol. 18, Iss. 1, pp. 19-27
Closed Access | Times Cited: 37
Emerging role of epigenetic therapies in cutaneous T-cell lymphomas
Jasmine Zain, David Kaminetzky, Owen A. O’Connor
Expert Review of Hematology (2010) Vol. 3, Iss. 2, pp. 187-203
Closed Access | Times Cited: 29
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream
Jeanine Peters‐Kennedy, Danny W. Scott, William H. Miller
Journal of Feline Medicine and Surgery (2008) Vol. 10, Iss. 6, pp. 593-599
Open Access | Times Cited: 28
New and Experimental Skin-Directed Therapies for Cutaneous Lymphomas
Árpád Farkas, Lajos Kemény, Lars E. French, et al.
Skin Pharmacology and Physiology (2009) Vol. 22, Iss. 6, pp. 322-334
Open Access | Times Cited: 27
Efforts to Counteract Locally the Effects of Systemic Immunosupression: A Review on the Use of Imiquimod, a Topical Immunostimulator in Organ Transplant Recipients
Myrto Trakatelli, Georgios Katsanos, Claas Ulrich, et al.
International Journal of Immunopathology and Pharmacology (2010) Vol. 23, Iss. 2, pp. 387-396
Open Access | Times Cited: 22
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update
Egle Ramelyte, Reinhard Dummer, Emmanuella Guenova
Expert Opinion on Investigational Drugs (2019) Vol. 28, Iss. 9, pp. 799-809
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top